Physician profile
Andra L Prum
NPI 1326026824
$1,866.28
in general payments reported to CMS, 2019-2025
34 companies · $57.23 in 2025
The $57.23 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $418 · 2021: $310 · 2022: $233 · 2023: $127 · 2024: $487 · 2025: $57.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.79 |
| Education | $155.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $293.55 | 2020-2023 | |
| Amgen INC. | $194.73 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Astellas Pharma US INC | $155.99 | 2024 | |
| Novo Nordisk INC | $136.49 | 2019-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $118.87 | 2021-2024 | Airsupra |
| Ucb, INC. | $101.02 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.36 | 2024-2025 | Gattex, Hyqvia |
| Lundbeck LLC | $70.73 | 2020-2024 | Rexulti |
| Kyowa Kirin, INC. | $66.05 | 2019-2020 | |
| Merz North America, INC. | $60.84 | 2020 | |
| Neurocrine Biosciences, INC. | $58.94 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $51.35 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $41.79 | 2019 | |
| Allergan, INC. | $39.16 | 2019-2022 | |
| Exact Sciences Corporation | $30.28 | 2023-2024 | Cologuard Collection Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $29.63 | 2022 | |
| Ethicon US, LLC | $27.62 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $26.98 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.76 | 2021 | |
| Mentor Worldwide LLC | $24.38 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Acorda Therapeutics, INC | $23.32 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $20.54 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $19.02 | 2024 | |
| Avanir Pharmaceuticals, INC. | $18.80 | 2020 | |
| Medtronic USA, INC. | $18.76 | 2020 | |
| Daiichi Sankyo INC. | $18.64 | 2024 | Injectafer |
| Ultragenyx Pharmaceutical INC. | $18.08 | 2021 | |
| Antares Pharma, INC. | $16.86 | 2024 | Xyosted |
| Csl Behring | $16.74 | 2020 | |
| Abbott Laboratories | $15.54 | 2024 | Proclaim |
| Tactile Systems Technology INC | $14.49 | 2022 | |
| Pfizer INC. | $13.80 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $13.65 | 2024 | Zoryve |
| Zyla Life Sciences, INC. | $11.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andra Prum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.